Copaxone and Rash - from FDA reports


Summary

Rash is found among people who take Copaxone, especially for people who are female, 40-49 old , have been taking the drug for 1 - 6 months, also take medication Ampyra, and have Gait disturbance. This review analyzes which people have Rash with Copaxone. It is created by eHealthMe based on reports of 32,646 people who have side effects when taking Copaxone from FDA , and is updated regularly.

What to expect?

If you take Copaxone and have Rash, find out what symptoms you could have in 1 year or longer.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>

On Nov, 18, 2017

32,646 people reported to have side effects when taking Copaxone.
Among them, 1,025 people (3.14%) have Rash


Number of reports submitted per year:

Could Copaxone cause Rash?

Time on Copaxone when people have Rash *:

  • < 1 month: 19.05 %
  • 1 - 6 months: 29.05 %
  • 6 - 12 months: 16.67 %
  • 1 - 2 years: 8.1 %
  • 2 - 5 years: 14.76 %
  • 5 - 10 years: 7.14 %
  • 10+ years: 5.24 %

Gender of people who have Rash when taking Copaxone *:

  • female: 82.34 %
  • male: 17.66 %

Age of people who have Rash when taking Copaxone *:

  • 0-1: 0.0 %
  • 2-9: 0.16 %
  • 10-19: 0.8 %
  • 20-29: 6.4 %
  • 30-39: 21.12 %
  • 40-49: 28.64 %
  • 50-59: 23.2 %
  • 60+: 19.68 %

Top conditions involved for these people *:

  • Gait Disturbance (57 people, 5.56%)
  • Depression (25 people, 2.44%)
  • Pain (19 people, 1.85%)
  • High Blood Cholesterol (14 people, 1.37%)
  • High Blood Pressure (12 people, 1.17%)

Top co-used drugs for these people *:

  • Ampyra (117 people, 11.41%)
  • Vitamin D (47 people, 4.59%)
  • Tysabri (47 people, 4.59%)
  • Avonex (43 people, 4.20%)
  • Provigil (31 people, 3.02%)

Top other side effects for these people *:

  • Itching (168 people, 16.39%)
  • Breathing Difficulty (156 people, 15.22%)
  • Urticaria (150 people, 14.63%)
  • Skin Blushing/flushing (88 people, 8.59%)
  • Chest Pain (87 people, 8.49%)

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

Want to find out more about the FDA reports used in the study? You can request them from FDA.

Do you have Rash when taking Copaxone?

Expand the study to include all drugs with the same ingredients

Rash and drugs with ingredients of glatiramer acetate.

Expand the study to include reports from both FDA and eHealthMe

Rash and Copaxone from FDA and eHealthMe reports

Copaxone

Copaxone has active ingredients of glatiramer acetate. It is often used in multiple sclerosis. (latest outcomes from Copaxone 33,173 users)

Rash

Rash has been reported by people with rheumatoid arthritis, high blood pressure, multiple sclerosis, hepatitis c, high blood cholesterol (latest reports from 290,944 Rash patients).

Browse all side effects of Copaxone

a b c d e f g h i j k l m n o p q r s t u v w x y z

Drugs that are associated with Rash

Rash

Could your condition cause Rash

Rash

Related studies

What would happen?

Forecast new side effects and undetected conditions when you take Copaxone and have Rash.

Questions to the study

More questions >